RIYADH: The Saudi Heart Association has signed a memorandum of understanding with AstraZeneca to support cardiac research, train healthcare practitioners and improve care for hypertension patients, SPA reported on Friday. The agreement comes as cardiovascular disease remains a major public health challenge in the Kingdom. Figures from the General Authority for Statistics show that 7.9 percent of people aged 15 and over had hypertension in 2024,…